| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
14-hydroxyandrost-4-ene-3,6,17-trione
1
relevant articles (0 outcomes,
0 trials/studies)
found for this Bio-Agent
Description: inhibits aromatase activity in human uterine tumors; structure given in first source
Also Known As:14-HAET; 14-OHAT; 14alpha-hydroxy-4-androstene-3,6,17-trione; androst-4-ene-3,6,17-trione-14-ol
Bio-Agent Context: Research Results
Related Diseases
| 1. | Endometrial Neoplasms (Endometrial Cancer)
06/01/1999
- "Five of the fifteen endometrial cancers and four of the nine ovarian cancers demonstrated decreased [3H]thymidine uptake or Ki67 labeling index after 14alpha-hydroxy-4-androstene-3,6,17-trione (NKS01) treatment"
Get all the results and reference details, order at left... |
| 2. | Ovarian Neoplasms (Ovarian Cancer)
06/01/1999
- "Five of the fifteen endometrial cancers and four of the nine ovarian cancers demonstrated decreased [3H]thymidine uptake or Ki67 labeling index after 14alpha-hydroxy-4-androstene-3,6,17-trione (NKS01) treatment"
Get all the results and reference details, order at left... |
| 2 Diseases and 1 more articles analyzed in the Research Interface, order at left... | |
Related Drugs and Biologics
| 1. | Thymidine
|
| 1 Drugs and Important Bio-Agents and 1 more articles analyzed in the Research Interface, order at left... | |
Research Interface Subscription
- Unlimited Searches
- 2 clicks from Disease to Drug to Evidence
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Detailed Relationship Timeline Charts
- Full Article Reference Details
- Includes Mobile Interface Subscription
- Request Institution License details >>
| Price: | $490.00 access via web interface, 1 year subscription |
Mobile Interface Subscription
- Access from any web enabled PDA or Phone
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Full Article Reference Details
- Try Mobile Interface >>
| Price: | $45.00 access via "curehunter.com/m", 1 year subscription |